Skip to main content
. Author manuscript; available in PMC: 2011 Jan 1.
Published in final edited form as: Cancer. 2010 Jan 1;116(1):8–19. doi: 10.1002/cncr.24702

Table 4.

Effects of PP2A gene haplotypes on breast cancer risk

Gene Copies of
Haplo-
type
Odds
ratio
95%
Confidence
Interval
P
value
Haplotype Cases Controls
PPP2R1A
C
    A: Recessive 298 675 ≤1 1
risk 151 211 2 1.63 1.3 – 2.1 0.0002*
CTAGGCA
    B: Dominant 252 344 0 1
protection 87 209 ≥1 0.555 0.41 – 0.76 0.0002*
PPP2R2A
A
    C: Recessive 170 393 ≤1 1
Risk 280 497 2 1.32 1.0 – 1.7 0.022
G
    D: Dominant 280 497 0 1
protection 170 393 ≥1 0.759 0.60 – 0.96 0.022
PPP2R5E
GCT
    E: Dominant 393 804 0 1
risk 55 82 ≥1 1.42 1.0 – 2.0 0.063
GA
    F: Recessive 144 245 ≤1 1
protection 304 637 2 0.776 0.6 – 1.0 0.057
*

Permuted P = 0.003